Expert Perspectives on the Role of Traditional Versus Emerging Therapies in Multiple Myeloma

In review of recent clinical data, expert panelists highlight novel therapeutic approaches in the setting of newly diagnosed and relapsed multiple myeloma.

EP. 1: Expert Perspectives on the Role of Traditional Versus Emerging Therapies in Multiple Myeloma

December 21st 2022

A video preview for an upcoming expert panelist discussion of recent updates in the multiple myeloma treatment landscape.

EP. 2: The Evolving Treatment Landscape of Transplant-Eligible Newly Diagnosed Multiple Myeloma

January 20th 2023

Opening discussion on the management of transplant-eligible newly diagnosed multiple myeloma, expert panelists consider the role of quadruplet therapy and transplant in this setting.

EP. 3: Should Every Patient With Newly Diagnosed MM Receive a Transplant?

January 20th 2023

In light of recent clinical trial data, key opinion leaders reflect on the appropriate selection of transplant for patients with newly diagnosed multiple myeloma.

EP. 4: Selecting The Appropriate Treatment in Transplant-Eligible Newly Diagnosed MM

January 30th 2023

A brief discussion how to select the appropriate treatment strategy in transplant-eligible newly diagnosed myeloma and whether there is a role for minimal residual disease in assessing response and treatment duration.

EP. 5: Approaching Induction Therapy for Patients With Transplant-Ineligible MM

January 30th 2023

Switching their focus to transplant-ineligible multiple myeloma, panelists review available triplet therapy regimens for induction therapy.